CSIMarket



Boston Scientific Corporation  (BSX)
Other Ticker:  
 
 

BSX's Operating Income Growth by Quarter and Year

Boston Scientific's Operating Income results by quarter and year




BSX Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 180.00 50.00 210.00
III Quarter September - 387.00 -205.00 383.00
II Quarter June - 262.00 -71.00 384.00
I Quarter March 466.00 370.00 146.00 319.00
FY   466.00 1,199.00 -80.00 1,296.00



BSX Operating Income first quarter 2022 Y/Y Growth Comment
Boston Scientific Corporation reported Operating Income improvement of 25.95% year on year in the first quarter 2022, to $ 466.00 millions, this is lower than Boston Scientific Corporation's recent average Operating Income rise of 65.01%.

Looking into first quarter 2022 results within Medical Equipment & Supplies industry 8 other companies have achieved higher Operating Income growth. While Boston Scientific Corporation' s Operating Income rise of 25.95% ranks overall at the positon no. 730 in the first quarter 2022.

Explain Operating Income growth


BSX Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - 260 % -76.19 % -45.88 %
III Quarter September - - - -2.3 %
II Quarter June - - - -5.65 %
I Quarter March 25.95 % 153.42 % -54.23 % 0 %
FY   - - - -13.94 %

Financial Statements
Boston Scientific's first quarter 2022 Operating Income $ 466.00 millions BSX's Income Statement
Boston Scientific's first quarter 2021 Operating Income $ 370.00 millions Quarterly BSX's Income Statement
New: More BSX's historic Operating Income Growth >>


BSX Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -53.49 % - -45.17 %
III Quarter September - 47.71 % - -0.26 %
II Quarter June - -29.19 % - 20.38 %
I Quarter March 158.89 % 640 % -30.48 % -17.78 %
FY (Year on Year)   - - - -13.94 %




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #47
Overall #730

Operating Income Y/Y Growth Statistics
High Average Low
1132.14 % 65.01 % -98.1 %
(Sep. 30, 2009)   (March 31, 2009)
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #9
Healthcare Sector #47
Overall #730
Operating Income Y/Y Growth Statistics
High Average Low
1132.14 % 65.01 % -98.1 %
(Sep. 30, 2009)   (March 31, 2009)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Boston Scientific's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
2400 % 89.21 % -90.76 %
(June 30, 2009)  


BSX's I. Quarter Q/Q Operating Income Comment
Boston Scientific Corporation achieved in the I. Quarter 2022 above company average sequential Operating Income doubling of 158.89%, to $ 466.00 millions, from $180.00 millions in the forth quarter.

Within Medical Equipment & Supplies industry 4 other companies have achieved higher Operating Income quarter on quarter growth. While Boston Scientific's Operating Income growth quarter on quarter, overall rank is 114.


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #12
Overall #114
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #12
Overall #114
Operating Income Q/Q Growth Statistics
High Average Low
2400 % 89.21 % -90.76 %
(June 30, 2009)  


BSX's I. Quarter Q/Q Operating Income Comment
Boston Scientific Corporation achieved in the I. Quarter 2022 above company average sequential Operating Income doubling of 158.89%, to $ 466.00 millions, from $180.00 millions in the forth quarter.

Within Medical Equipment & Supplies industry 4 other companies have achieved higher Operating Income quarter on quarter growth. While Boston Scientific's Operating Income growth quarter on quarter, overall rank is 114.


Boston Scientific's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ 1,295.00 $ 1,199.00 $ 1,069.00 $ 477.00 $ 144.00
Y / Y Operating Income Growth (TTM) 799.31 % - 1236.25 % -28.59 % -87.18 %
Year on Year Operating Income Growth Overall Ranking # 43 # 0 # 28 # 1697 # 1953
Seqeuential Operating Income Change (TTM) 8.01 % 12.16 % 124.11 % 231.25 % -
Seq. Operating Income Growth (TTM) Overall Ranking # 631 # 359 # 66 # 82 # 0




Cumulative Operating Income growth Comment
Boston Scientific saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 799.31% year on year, to $ 1,295 millions if the fiscal year would have ended in Mar 31 2022.
Boston Scientific's trailing twelve months Operating Income growth was higher than company's average 176.61% and higher than % growth in Dec 31 2021.
But sequential rise was less at 8.01 % from $1199 millions achieved in twelve months ending a quarter Dec 31 2021.
We witness slowdown in progress, more noticeable if you pay attention to the average Q/Q TTM Operating Income rise which is better at51.04% Hailey Hernandez wrote.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 0 to 43.

Operating Income TTM Q/Q Growth Statistics
High Average Low
1141.67 %
51.04 %
-91.34 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 9
Healthcare Sector # 5
Overall # 43

Operating Income TTM Y/Y Growth Statistics
High Average Low
2972.22 %
176.61 %
-95.08 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 45
S&P 500 # 631
Cumulative Operating Income growth Comment
Boston Scientific saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 799.31% year on year, to $ 1,295 millions if the fiscal year would have ended in Mar 31 2022.
Boston Scientific's trailing twelve months Operating Income growth was higher than company's average 176.61% and higher than % growth in Dec 31 2021.
But from the previous reporting period increase was slower at 8.01 % from $1199 millions reported in twelve months ending a quarter before.
We witness stagnation happening, more obvious as we look at typical Q/Q TTM historic rise which is higher at 51.04%.
The growth was much stronger from twelve months ended Dec 31 2021 exhibited at 8.01 % rise from $1199 millions in the period from Dec 31 2021 to Mar 31 2021.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 0 to 43.

Operating Income TTM Q/Q Growth Statistics
High Average Low
1141.67 %
51.04 %
-91.34 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 9
Healthcare Sector # 5
Overall # 43

Operating Income TTM Y/Y Growth Statistics
High Average Low
2972.22 %
176.61 %
-95.08 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 45
S&P 500 # 631




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
BSX's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for BSX's Competitors
Operating Income Growth for Boston Scientific's Suppliers
Operating Income Growth for BSX's Customers

You may also want to know
BSX's Annual Growth Rates BSX's Profitability Ratios BSX's Asset Turnover Ratio BSX's Dividend Growth
BSX's Roe BSX's Valuation Ratios BSX's Financial Strength Ratios BSX's Dividend Payout Ratio
BSX's Roa BSX's Inventory Turnover Ratio BSX's Growth Rates BSX's Dividend Comparisons



Companies with similar Operating Income doubling for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Iqvia Holdings Inc 44.74%$ 44.737 millions
The Pennant Group Inc 44.20%$ 44.203 millions
Abcellera Biologics Inc 42.31%$ 42.307 millions
Bio rad Laboratories Inc 42.20%$ 42.197 millions
Abbott Laboratories38.07%$ 38.075 millions
Corcept Therapeutics Inc36.31%$ 36.312 millions
Medpace Holdings Inc 34.88%$ 34.883 millions
Bio techne Corp31.80%$ 31.797 millions
Bristol myers Squibb Company27.79%$ 27.790 millions
Ironwood Pharmaceuticals inc 27.42%$ 27.420 millions
Boston Scientific Corporation25.95%$ 25.946 millions
Tenet Healthcare Corp24.62%$ 24.615 millions
Glucotrack Inc.21.99%$ 21.987 millions
Syneos Health Inc 21.11%$ 21.111 millions
Apollo Medical Holdings Inc 20.34%$ 20.339 millions
Charles River Laboratories International inc 20.27%$ 20.270 millions
Incyte Corp17.96%$ 17.959 millions
Vertex Pharmaceuticals Inc17.24%$ 17.241 millions
Utah Medical Products Inc16.31%$ 16.307 millions
Organon and Co 15.91%$ 15.914 millions
Sotera Health Company15.37%$ 15.374 millions
Avantor Inc 15.28%$ 15.284 millions
Abbvie Inc 14.96%$ 14.965 millions
Atrion Corporation14.77%$ 14.769 millions
Edwards Lifesciences Corporation14.42%$ 14.420 millions
Regeneron Pharmaceuticals Inc 13.10%$ 13.103 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GIA's Profile

Stock Price

GIA's Financials

Business Description

Fundamentals

Charts & Quotes

GIA's News

Suppliers

GIA's Competitors

Customers & Markets

Economic Indicators

GIA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071